Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RXII

RXi Pharmaceuticals

$0.52

-0.0028 (-0.54%)

16:31
09/15/17
09/15
16:31
09/15/17
16:31
Hot Stocks
RXi Pharmaceuticals CBO Eliseev to leave company »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

RXII

RXi Pharmaceuticals

$0.52

-0.007 (-1.32%)

07:09
09/15/17
09/15
07:09
09/15/17
07:09
Hot Stocks
BioAxone BioSciences awarded NINDS SBIR funding to develop BA-434 »

BioAxone BioSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Over a week ago
RXII

RXi Pharmaceuticals

07:10
09/06/17
09/06
07:10
09/06/17
07:10
Hot Stocks
RXi Pharmaceuticals announces completion of enrollment in Phase 2 trial »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Over a month ago
RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

RXII

RXi Pharmaceuticals

$0.58

0.01001 (1.76%)

07:08
08/09/17
08/09
07:08
08/09/17
07:08
Hot Stocks
RXi Pharmaceuticals enters common stock purchase agreement for up to $15M »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

  • 26

    Sep

RXII

RXi Pharmaceuticals

07:14
08/08/17
08/08
07:14
08/08/17
07:14
Hot Stocks
RXi Pharmaceuticals selects two sd-rxRNA compounds for preclinical development »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

  • 26

    Sep

RXII

RXi Pharmaceuticals

$0.59

-0.0081 (-1.35%)

08:19
08/03/17
08/03
08:19
08/03/17
08:19
Hot Stocks
RXi Pharmaceuticals granted 180-day listing compliance extension »

RXi Pharmaceuticals has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

RXII

RXi Pharmaceuticals

$0.68

-0.0161 (-2.31%)

17:31
07/14/17
07/14
17:31
07/14/17
17:31
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

RXII

RXi Pharmaceuticals

$0.56

-0.0001 (-0.02%)

07:09
06/21/17
06/21
07:09
06/21/17
07:09
Hot Stocks
RXi Pharmaceuticals completes enrollment of RXI-109 Phase 1/2 clinical trial »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
RXII

RXi Pharmaceuticals

$0.64

0.0502 (8.53%)

07:06
06/12/17
06/12
07:06
06/12/17
07:06
Hot Stocks
RXi Pharmaceuticals initiates consumer/functional testing program with RXI-231 »

RXi Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.